Atlas Trials

Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes

Clinical trial NCT03579160 · TERMINATED

Trial details

NCT number
NCT03579160
Sponsor
Brigham and Women's Hospital
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Wound of SkinWound HealSurgical WoundFull Thickness Skin Graft Healing
Start date
2019-01-02
Primary completion
2022-01-10
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.